Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Fortis Healthcare Q1 Review: Analysts Bullish Despite Short-Term Margin Pressure — Should You Buy?

    1 day ago

    For the first quarter (Q1 FY27), Fortis delivered a strong top-line performance with consolidated revenue jumping 17.4% year-on-year to ₹2,545 crore, propelled by steady demand across hospital services and a recovering diagnostics arm.
    Click here to Read More
    Previous Article
    Dhoot Transmission IPO GMP Today: Grey Market Premium Signals 30% Listing Gain Ahead Of IPO Opening
    Next Article
    Kaynes Technology Says A 'Global Player' Wants Entire PCB Capacity Ahead Of Production Launch

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment